WallStSmart

Jerash Holdings US Inc (JRSH)vsErmenegildo Zegna NV (ZGN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ermenegildo Zegna NV generates 1018% more annual revenue ($1.98B vs $176.86M). ZGN leads profitability with a 4.0% profit margin vs 2.8%. JRSH trades at a lower P/E of 14.8x. JRSH earns a higher WallStSmart Score of 51/100 (C-).

JRSH

Buy

51

out of 100

Grade: C-

Growth: 8.0Profit: 5.0Value: 7.7Quality: 9.0
Piotroski: 4/9Altman Z: 4.75

ZGN

Avoid

32

out of 100

Grade: F

Growth: 4.7Profit: 6.0Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: 1.76
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

JRSHUndervalued (+36.5%)

Margin of Safety

+36.5%

Fair Value

$5.34

Current Price

$5.30

$0.04 discount

UndervaluedFair: $5.34Overvalued

Intrinsic value data unavailable for ZGN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JRSH6 strengths · Avg: 9.2/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

EPS GrowthGrowth
418.1%10/10

Earnings expanding 418.1% YoY

Altman Z-ScoreHealth
4.7510/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

P/E RatioValuation
14.8x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
26.7%8/10

Revenue surging 26.7% year-over-year

ZGN1 strengths · Avg: 8.0/10
Price/BookValuation
2.7x8/10

Reasonable price relative to book value

Areas to Watch

JRSH3 concerns · Avg: 3.0/10
Market CapQuality
$69.60M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.8%3/10

ROE of 2.8% — below average capital efficiency

Profit MarginProfitability
2.8%3/10

2.8% margin — thin

ZGN4 concerns · Avg: 3.3/10
P/E RatioValuation
34.4x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.764/10

Distress zone — elevated risk

Profit MarginProfitability
4.0%3/10

4.0% margin — thin

EPS GrowthGrowth
-49.2%2/10

Earnings declined 49.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : JRSH

The strongest argument for JRSH centers on Price/Book, EPS Growth, Altman Z-Score. Revenue growth of 26.7% demonstrates continued momentum.

Bull Case : ZGN

The strongest argument for ZGN centers on Price/Book.

Bear Case : JRSH

The primary concerns for JRSH are Market Cap, Return on Equity, Profit Margin. Thin 2.8% margins leave little buffer for downturns.

Bear Case : ZGN

The primary concerns for ZGN are P/E Ratio, Altman Z-Score, Profit Margin. Thin 4.0% margins leave little buffer for downturns.

Key Dynamics to Monitor

JRSH profiles as a growth stock while ZGN is a value play — different risk/reward profiles.

JRSH carries more volatility with a beta of 0.98 — expect wider price swings.

JRSH is growing revenue faster at 26.7% — sustainability is the question.

ZGN generates stronger free cash flow (110M), providing more financial flexibility.

Bottom Line

JRSH scores higher overall (51/100 vs 32/100) and 26.7% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Jerash Holdings US Inc

CONSUMER CYCLICAL · APPAREL MANUFACTURING · USA

Jerash Holdings (USA), Inc., manufactures and exports custom and tailored sports and outdoor apparel. The company is headquartered in Fairfield, New Jersey.

Visit Website →

Ermenegildo Zegna NV

CONSUMER CYCLICAL · APPAREL MANUFACTURING · USA

Ermenegildo Zegna NV designs, manufactures, exports and sells men's clothing.

Want to dig deeper into these stocks?